{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:24:29Z","timestamp":1783603469019,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The adverse effects of lactic acidosis in the cancer microenvironment have been increasingly recognized. Dichloroacetate (DCA) is an orally bioavailable, blood brain barrier penetrable drug that has been extensively studied in the treatment of mitochondrial neurologic conditions to reduce lactate production. Due to its effect reversing aerobic glycolysis (i.e., Warburg-effect) and thus lactic acidosis, DCA became a drug of interest in cancer as well. Magnetic resonance spectroscopy (MRS) is a well-established, non-invasive technique that allows detection of prominent metabolic changes, such as shifts in lactate or glutamate levels. Thus, MRS is a potential radiographic biomarker to allow spatial and temporal mapping of DCA treatment. In this systematic literature review, we gathered the available evidence on the use of various MRS techniques to track metabolic changes after DCA administration in neurologic and oncologic disorders. We included <jats:italic>in vitro<\/jats:italic>, animal, and human studies. Evidence confirms that DCA has substantial effects on lactate and glutamate levels in neurologic and oncologic disease, which are detectable by both experimental and routine clinical MRS approaches. Data from mitochondrial diseases show slower lactate changes in the central nervous system (CNS) that correlate better with clinical function compared to blood. This difference is most striking in focal impairments of lactate metabolism suggesting that MRS might provide data not captured by solely monitoring blood. In summary, our findings corroborate the feasibility of MRS as a pharmacokinetic\/pharmacodynamic biomarker of DCA delivery in the CNS, that is ready to be integrated into currently ongoing and future human clinical trials using DCA.<\/jats:p>","DOI":"10.3389\/fonc.2023.1077461","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:19:09Z","timestamp":1679030349000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"David O.","family":"Kamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka","family":"Chinnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Bettegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Stacpoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Oeltzschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.taap.2013.09.005","article-title":"Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: A role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation","volume":"273","author":"Kumar","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-k+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"key":"B4","article-title":"Correlation of high lactate levels in head and neck tumors with incidence of metastasis","volume":"150","author":"Walenta","year":"1997","journal-title":"Am J Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.3390\/cancers14153769","article-title":"Refining the role of pyruvate dehydrogenase kinases in glioblastoma development","volume":"14","author":"Larrieu","year":"2022","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.molcel.2022.06.030","article-title":"Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma","volume":"82","author":"Torrini","year":"2022","journal-title":"Mol Cell"},{"key":"B8","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical Cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)01630-3","article-title":"Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer","volume":"51","author":"Brizel","year":"2001","journal-title":"Int J Radiat Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(89)90051-6","article-title":"The pharmacology of dichloroacetate","volume":"38","author":"Stacpoole","year":"1989","journal-title":"Metabolism"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2014.08.005","article-title":"Dichloroacetate and cancer: New home for an orphan drug","volume":"1864","author":"Kankotia","year":"2014","journal-title":"Biochim Biophys Acta BBA - Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90259-6","article-title":"Lactic acidosis and other mitochondrial disorders","volume":"46","author":"Stacpoole","year":"1997","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.25766","article-title":"Volumetric spiral chemical shift imaging of hyperpolarized [2-13c]pyruvate in a rat c6 glioma model","volume":"75","author":"Park","year":"2016","journal-title":"Magn Reson Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.2935","article-title":"Measuring mitochondrial metabolism in rat brain in vivo using MR spectroscopy of hyperpolarized [2-13C]pyruvate","volume":"26","author":"Park","year":"2013","journal-title":"NMR Biomed"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2012.05.012","article-title":"Use of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the normal rat","volume":"30","author":"Hu","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1992.140","article-title":"Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats","volume":"12","author":"Chang","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71031205.x","article-title":"Age-related differences in the effect of dichloroacetate on postischemic lactate and acid clearance measured In vivo using magnetic resonance spectroscopy and microdialysis","volume":"71","author":"Corbett","year":"1998","journal-title":"J Neurochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/metabo11060335","article-title":"Enhancing metabolic imaging of energy metabolism in traumatic brain injury using hyperpolarized [1-13C]Pyruvate and dichloroacetate","volume":"11","author":"DeVience","year":"2021","journal-title":"Metabolites"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.6.1193","article-title":"Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders","volume":"45","author":"Stefano","year":"1995","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1376","article-title":"MR spectroscopy study of dichloroacetate treatment after ischemic stroke","volume":"55","author":"Graham","year":"2000","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2009.02815.x","article-title":"Treatment for Leigh syndrome by monitoring dichloroacetate concentration","volume":"51","author":"Katsumi","year":"2009","journal-title":"Pediatr Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/BF01957508","article-title":"Therapy of complex I deficiency: Peripheral neuropathy during dichloroacetate therapy","volume":"154","author":"Kurlemann","year":"1995","journal-title":"Eur J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.6.849","article-title":"Magnetic resonance spectroscopy: Use in monitoring MELAS treatment","volume":"55","author":"Pavlakis","year":"1998","journal-title":"Arch Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(98)00095-3","article-title":"Proton magnetic resonance spectroscopy to study the metabolic changes in the brain of a patient with Leigh syndrome","volume":"21","author":"Takahashi","year":"1999","journal-title":"Brain Dev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(96)00248-1","article-title":"Dichloroacetate treatment in Leigh syndrome caused by mitochondrial DNA mutation","volume":"145","author":"Takanashi","year":"1997","journal-title":"J Neurol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3892\/ijo.2017.4029","article-title":"In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging","volume":"51","author":"Anemone","year":"2017","journal-title":"Int J Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.281","article-title":"Dichloroacetate induces autophagy in colorectal cancer cells and tumours","volume":"111","author":"Lin","year":"2014","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3101","article-title":"NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells","volume":"27","author":"Kailavasan","year":"2014","journal-title":"NMR Biomed"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13176","article-title":"Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models","volume":"7","author":"Neveu","year":"2016","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/metabo11060350","article-title":"Metabolic response of pancreatic carcinoma cells under treatment with dichloroacetate","volume":"11","author":"Feuerecker","year":"2021","journal-title":"Metabolites"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1158\/0008-5472.CAN-15-0840","article-title":"IDH1 mutation induces reprogramming of pyruvate metabolism","volume":"75","author":"Izquierdo-Garcia","year":"2015","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-015-3523-5","article-title":"The neuroimaging of Leigh syndrome: case series and review of the literature","volume":"46","author":"Bonfante","year":"2016","journal-title":"Pediatr Radiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310408","article-title":"MELAS: Clinical features, biochemistry, and molecular genetics","volume":"31","author":"Ciafaloni","year":"1992","journal-title":"Ann Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos319","article-title":"Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized 13C magnetic resonance spectroscopic imaging","volume":"15","author":"Park","year":"2013","journal-title":"Neuro-Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022106910017","article-title":"Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis","volume":"61","author":"Roslin","year":"2003","journal-title":"J Neurooncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: A cancer hallmark even warburg did not anticipate - ScienceDirect","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2808","article-title":"First-in-Human phase I study to evaluate the brain-penetrant PI3K\/mTOR inhibitor GDC-0084 in patients with progressive or recurrent high-grade glioma","volume":"26","author":"Wen","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"now159","DOI":"10.1093\/neuonc\/now159","article-title":"Association of early changes in 1 h MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen","volume":"91","author":"Nelson","year":"2016","journal-title":"Neuro-Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1077461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:19:12Z","timestamp":1679030352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1077461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":38,"alternative-id":["10.3389\/fonc.2023.1077461"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1077461","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"article-number":"1077461"}}